查詢結果分析
來源資料
相關文獻
- 過氧小體增殖活化受體、代謝症候群與癌症
- 第2型糖尿病、游離脂肪酸、脂肪細胞激素與PPARγ促效劑
- 胰島素、脂肪與癌症:藥理學觀點
- Community-based Study on Summer-Winter Difference in Insulin Resistance in Kin-Chen, Kinmen, Taiwan
- 胰島素阻抗對代謝症候群與脂肪肝之影響
- 代謝失能脂肪肝疾病之定義與診斷
- ACARBOSE使用於口服降糖藥物失效之第2型糖尿病患者--臨床評估
- 非胰島素依賴型糖尿病患者血脂肪的異常代謝
- 耐力運動對脂肪代謝之影響
- Relationship Between Fasting Leptin and Insulin Concentrations in Type 2 Diabetes Mellitus Patients
頁籤選單縮合
題 名 | 過氧小體增殖活化受體、代謝症候群與癌症=PPARs, Metabolic Syndrome and Cancer |
---|---|
作 者 | 唐正乾; 郭傑; 陳滄山; 許世元; | 書刊名 | 內科學誌 |
卷 期 | 18:5 2007.10[民96.10] |
頁 次 | 頁244-255 |
分類號 | 415.13 |
關鍵詞 | 代謝症候群; 過氧小體增殖活化受體; 第2型糖尿病; 冠心病; 癌症; 胰島素; 脂肪; Metabolic syndrome; PPAR; T2DM; CHD; Cancer; Insulin; Fat; |
語 文 | 中文(Chinese) |
中文摘要 | 過氧小體增殖活化受體(peroxisome proliferators-activated receptors, PPARs)屬於核激素受體超級家族的成員,PPARs主要的生理作用,包括脂質代謝、細胞增殖、分化、胰島素敏感性與發炎訊息等。證據顯示,PPARs與代謝症候群及其併發症之問有相當的因果關係,包括肥胖、第2型糖尿病與冠心病,且與癌症關係密切。調控PRARs的藥物,如PRARα與PPARγ激活劑,臨床上分別用於改善高三酸甘油酯血症與胰島素阻抗,對代謝症候群及其相關併發症有正面意義。最近的研究指出,激活PPARs能抑制發炎訊息傳遞,因而減緩癌化病程,唯仍需更多的支持證據;但無論如何,多瞭解癌症、代謝症候群與PPARs之問細胞生理及代謝作用的關聯性,對於癌症與代謝症候群及其相關併發症的預防與治療,是有正面的意義。 |
英文摘要 | Peroxisome proliferator-activated receptors are members of nuclear hormone receptor superfamily. PPARs play an important role in biological functions including lipid metabolism, cell proliferation, differentiation, insulin sensitivity, and inflammatory signaling. Growing evidence shows that PPARs have a causative relationship with the metabolic syndrome and its related complications including obesity, T2DM, and CHD, and even with cancer. The PPARα and PPARγ agonists are clinic targets for hypertriglyceridemia and insulin resistance, respectively, and drugs that modulate these receptors have been proved to improve metabolic syndrome and its related complications. Recently, studies have shown that the activation of PPARs may inhibit carcinogenesis by downregulating inflammatory signaling, although more evidences are needed. However, a better understanding of diverse range of physiological processes and the relationship among cancer, metabolic syndrome and PPARs may be helpful in elucidating more preventive avenues to manage cancer and metabolic syndrome and its related complications. |
本系統中英文摘要資訊取自各篇刊載內容。